Categories: CBD

FDA Report Warning Letters: CBD Companies Coming Up Short

 The U.S. Food and Drug Administration is in charge of regulating the CBD products produced and sold on American soil. Companies like Treat CBD Brand didn’t have those problem. Part of this mandate includes them conducting sample studies with a focus on understanding if CBD companies are mislabeling their products. To that end a report was sent by the FDA, just this week, to the appropriations committees of the U.S. House of Representatives and Senate. FDA CBD Warning Letters were sent out. The title of the report was, “Warning Letters and Test Results for Cannabidiol-Related Products”

 

Top FDA CBD Warning Letters: 

Firm State Purchase Website
Koi CBD LLC CA koicbd.com
Pink Collections Inc. CA mrpinkcbd.com
Noli Oil LLC TX nolioil.com
Natural Native LLC OK naturalnative.com
Whole Leaf Organics LLC CA wholeleaforganics.com
Infinite Product Company LLLP CO infinitecbd.com
Apex Hemp Oil LLC OR apexhempoil.com
Bella Rose Labs NY bellaroselab.com
Sunflora Inc. FL sunflora.org
Healthy Hemp Strategies LLC (d/b/a) Curapure CA curapure.com
Private I Salon LLC NC privateirxcbd.com
Organix Industries Inc. (d/b/a) Plant Organix CA plantorganix.com
Red Pill Medical Inc. AZ redpillmedical.com
Sabai Ventures Ltd. CA getsabaidee.com
Daddy Burt LLC (d/b/a) Daddy Burt Hemp Co. KY daddyburt.com
Rooted Apothecary LLC FL rootedapoth.com
Herbal Healer Academy, Inc. AR herbalhealer.com
Alternative Laboratories FL alternativelabs.com
Curaleaf Inc. MA curaleafhemp.com
Advanced Spine and Pain LLC (d/b/a Relievus) NJ relievus.com
Nutra Pure LLC WA cbdpure.com
PotNetwork Holdings Inc. FL diamondcbd.com

 

The sample testing shows that 59% of the CBD products sampled had much less CBD than advertised, additionally there were other samples showing a drastically higher amount of CBD than advertised. This is particularly bad for the industry because concerns over CBD safety are stopping the FDA from approving the free commerce of CBD products in the U.S.

In other words, the lack of honesty and transparency being shown by CBD companies currently is stopping the development and implementation of regulatory framework for CBD. Full transparency, a marketplace with an ethical foundation, and enough data to back them up are all that will allow the FDA to verify its safety. And those regulations will enable the marketplace to expand exponentially. One can only hope that the entrepreneurs impacted by this are taking note.  

 

 

Joseph A. Padilla

Recent Posts

What does CBD really do in the Body?

What does CBD really do in the Body? Many people are curious about exactly how…

4 years ago

Is the new component THCP stronger than THC?

Good news! Due to continuing research, the potential of cannabis is becoming abundantly clear. Nearly…

5 years ago

This website uses cookies.